CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cydan Development, Inc., an orphan drug accelerator dedicated to creating therapies that impact the lives of people living with rare genetic diseases, today marked its support of Rare Disease Day with a gift to the National Organization of Rare Disorders (NORD) to support its Natural History Study Project being developed in collaboration with the U.S. Food and Drug Administration.
